Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

China · Delayed Price · Currency is CNY

25.30

-0.10 (-0.39%)

May 6, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research and Development, Production and Sales of Pharmaceuticals	1.06B	925.39M	848.19M	896.02M	807.69M
Research and Development, Production and Sales of Pharmaceuticals Growth	14.81%	9.10%	-5.34%	10.94%	26.95%
Total	1.06B	925.39M	848.19M	896.02M	807.69M
Total Growth	14.81%	9.10%	-5.34%	10.94%	26.95%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	1.06B	925.39M	848.19M	896.02M	807.69M
China Growth	14.81%	9.10%	-5.34%	10.94%	26.95%
Total	1.06B	925.39M	848.19M	896.02M	807.69M
Total Growth	14.81%	9.10%	-5.34%	10.94%	26.95%

Source: S&P Global Market Intelligence.